These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. On biological half-life of potassium in man. Rahola T; Suomela M Ann Clin Res; 1975 Apr; 7(2):62-5. PubMed ID: 1181976 [TBL] [Abstract][Full Text] [Related]
5. Estimation of total body potassium in normal adolescents by whole-body counting: age and sex differences. Novak LP; Tauxe WN; Orvis AL Med Sci Sports; 1973; 5(3):147-55. PubMed ID: 4201145 [No Abstract] [Full Text] [Related]
6. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting. Pike VW; Aigbirhio FI; Freemantle CA; Page BC; Rhodes CG; Waters SL; Jones T; Olsson P; Ventresca GP; Tanner RJ Drug Metab Dispos; 1995 Aug; 23(8):832-9. PubMed ID: 7493550 [TBL] [Abstract][Full Text] [Related]
7. Xenon-133, 127Xe, and 125Xe for lung function investigations: a dosimetric comparison. Goddard BA; Ackery DM J Nucl Med; 1975 Aug; 16(8):780-6. PubMed ID: 1177051 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous measurement of 59Fe and 51Cr in iron absorption studies using a whole-body scanner with mobile shielding. Marx JJ; van den Beld B; van Dongen R; Strackee LH Nuklearmedizin; 1980 Jul; 19(3):140-5. PubMed ID: 6780983 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of fat-free mass by whole-body counter in Japanese healthy young adults. Morita N; Takamura N; Murakami T; Jo O; Aoyagi K; Yamashita S; Okumura Y Radiat Prot Dosimetry; 2007; 123(1):128-30. PubMed ID: 16963436 [TBL] [Abstract][Full Text] [Related]
10. Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma. Dauer LT; St Germain J; Williamson MJ; Zanzonico P; Modak S; Cheung NK; Divgi C Health Phys; 2007 Jan; 92(1):33-9. PubMed ID: 17164597 [TBL] [Abstract][Full Text] [Related]
11. Xe133 elimination from human fat during negative- and positive-pressure breathing. Balldin UI; Linér MH Undersea Biomed Res; 1976 Jun; 3(2):163-9. PubMed ID: 781973 [TBL] [Abstract][Full Text] [Related]
12. Relationship of subcutaneous adipose tissue blood flow to total body fat mass. Nielsen SL; Larsen OA Bibl Anat; 1973; 11():411-6. PubMed ID: 4789072 [No Abstract] [Full Text] [Related]
13. The effects of body position and a vasodilator on xenon133 elimination from human subcutaneous fat. Balldin UI Undersea Biomed Res; 1976 Dec; 3(4):379-85. PubMed ID: 10897864 [TBL] [Abstract][Full Text] [Related]
14. A clinical comparison of Xe-127 and Xe-133 for ventilation studies. Atkins HL; Susskind H; Klopper JF; Ansari AN; Richards P; Fairchild RG J Nucl Med; 1977 Jul; 18(7):653-9. PubMed ID: 874143 [TBL] [Abstract][Full Text] [Related]
15. Radiation absorbed dose from technetium-99m DTPA. Smith T; Zanelli GD; Veall N J Nucl Med; 1987 Feb; 28(2):240-3. PubMed ID: 3100735 [TBL] [Abstract][Full Text] [Related]
16. Effect of mass, at a fixed height, on the counting efficiency of a BOMAB phantom in three types of whole body counter modeled by MCNP5. Kramer GH; Capello K; Phan Q Health Phys; 2008 Aug; 95(2):234-40. PubMed ID: 18617805 [TBL] [Abstract][Full Text] [Related]
19. Whole body autoradiographic and quantitative tissue distribution studies with 14C-cefotaxime in the rat. Stevens LA; Ings RM; Fromson JM; Coombes JD Arzneimittelforschung; 1984; 34(12):1723-9. PubMed ID: 6099126 [TBL] [Abstract][Full Text] [Related]
20. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]